Okay, I’m ready to analyze the article and prepare the details for the prompt.
STEP 1 – ANALYSIS
primarykeywords: proteogenomics protein variants genetic mutations cancer research moPepGen precision medicine audience: Researchers, scientists, healthcare professionals, and anyone interested in advancements in cancer research, proteomics, and precision medicine.tone: Informative, scientific, hopeful, and slightly technical. datelinelocation: LOS ANGELES
* evergreenbackgroundtopics: genomics, proteomics, cancer biology, bioinformatics, precision medicine, drug revelation, immunotherapy.
I will now provide the completed prompt, ready for you to copy and paste.
text
SUPER-PROMPT v11 - Evergreen News+, Publish-Only, feature-Rich
copy everything in this box into your LLM.
Swap each 🔶 PLACEHOLDER with your own value (site name, canonical URL, etc.).
WordPress will inject raw source HTML where
moPepGen is a graph-based algorithm that uncovers non-canonical peptides with variant combinations. Credit: Nature Biotechnology (2025). DOI: 10.1038/s41587-025-02701-0
LOS ANGELES - Scientists at UCLA and the University of Toronto have developed an advanced computational tool, called moPepGen, that helps identify previously invisible genetic mutations in proteins, unlocking new possibilities in cancer research and beyond.
The tool, described in Nature Biotechnologywill help understand how changes in our DNA affect proteins and ultimately contribute to cancer, neurodegenerative diseases, and other conditions. It provides a new way to create diagnostic tests and to find treatment targets previously invisible to researchers.
Proteogenomics combines the study of genomics and proteomics to provide a comprehensive molecular profile of diseases. However, a major challenge has been the inability to accurately detect variant peptides, limiting the ability to identify genetic mutations at the protein level. Existing proteomic tools often fail to capture the full diversity of protein variations.
To overcome this challenge, the researchers developed moPepGen, which enables more precise identification of protein variations.
"We developed moPepGen to help researchers determine which genetic variants are truly expressed at the protein level, addressing a long-standing challenge in the proteogenomic community," said Chenghao Zhu, Ph.D., a postdoctoral scholar at the department of human genetics at UCLA and co-first author of the study.
"Our tool considerably improves the detection of hidden protein variations by using a graph-based approach to efficiently process all types of genetic changes. This provides a more comprehensive view of protein diversity and gives researchers a much more accurate picture of how mutations influence disease."
This level of precision is critical because proteins play a fundamental role in nearly every biological function, and alterations in their structures can signal disease progression, especially in cancer. Yet, analyzing proteins to detect thes changes remains an immense computational challenge.
Unlike existing methods,which primarily detect simple genetic changes such as single amino acid substitutions,moPepGen is designed to identify a wide range of protein variations caused by choice splicing,circular RNAs,gene fusions,RNA editing,and other complex genetic modifications.
The tool systematically models how genes are expressed and translated into proteins, significantly expanding the ability to detect disease-associated mutations.
"Until now, there hasn't been a practical way to handle the enormous complexity of genetic and transcriptomic variation," said Zhu. "The algorithm works rapidly, even when analyzing massive amounts of data, and is designed to function across multiple technologies and species."
To demonstrate its effectiveness, the team used moPepGen to analyze proteogenomic data from five prostate tumors, eight kidney tumors, and 376 cell lines.
They found that moPepGen successfully identified previously undetectable protein variations linked to genetic mutations, gene fusions, and other molecular changes.It also proved more sensitive and comprehensive than previous methods, detecting four times more unique protein variants than older approaches.
Discover the latest in science, tech, and space with over 100,000 subscribers who rely on Phys.org for daily insights.
Sign up for our free newsletter and get updates on breakthroughs,
innovations, and research that matter-daily or weekly.
The researchers noted that one of moPepGen's most exciting applications is in immunotherapy, as it can identify cancer-specific variant peptides that may serve as neoantigen candidates, which is key to developing personalized cancer vaccines and cell therapies.
"By making it easier to analyze complex protein variations, moPepGen has the potential to advance research in cancer, neurodegenerative diseases, and other fields where understanding protein diversity is critical," said Paul Boutros, Ph.D., professor of urology and human genetics at the David Geffen School of Medicine at UCLA, director of cancer data science at the UCLA Health Jonsson Comprehensive Cancer Center and co-senior author of the study.
"It bridges the gap between genetic data and real-world protein expression, unlocking new possibilities in precision medicine and beyond."
The tool is freely available for researchers and can integrate with existing proteomics workflows, making it accessible for labs worldwide.
The study's other first author is Lydia Liu,Ph.D., and the other senior author is Thomas Kislinger, Ph.D., both from the University of Toronto. A full list of authors is available in the study.
Boutros also serves as the interim vice dean for research at the David Geffen School of Medicine at UCLA, associate director of cancer informatics at the UCLA Institute for Precision Health, and is a member of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research.
More information:
Chenghao Zhu et al, Identification of non-canonical peptides with moPepGen, Nature Biotechnology (2025). Two: 10.1038/S41587-025-02701-0
Provided by
University of California,Los Angeles
Citation:
Advanced software uncovers elusive protein variants tied to genetic mutations (2025, June 16)
retrieved 16 June 2025
from
This document is subject to copyright. Apart from any fair dealing to private study or research, no
part may be reproduced without the written permission.The content is provided for information purposes only.
The Archynetys Technology & Science Desk covers AI, consumer technology, internet culture, startups, cybersecurity, space, and scientific discovery. Coverage focuses on explaining why developments matter, who they affect, and what the next-order implications are for readers and industry.
